Cite

HARVARD Citation

    Blauvelt, A. et al. (2020). A study comparing the biologic drugs ixekizumab and guselkumab for the treatment of moderate‐to‐severe plaque psoriasis. British journal of dermatology. p. e193. [Online]. 
  
Back to record